Overactive bladder syndrome. other specified disorders of bladder
Conditions
Interventions
Intervention 1: The control group received 2 mg tolterodine (regular treatment) and 60 mg placebo twice a day. Then, their blood pressure was measured using a pressure set and symptoms of urinary syst
Treatment - Drugs
The control group received 2 mg tolterodine (regular treatment) and 60 mg placebo twice a day. Then, their blood pressure was measured using a pressure set and symptoms of urinary system were checked
The experiment group received 2 mg tolterodine and 60 mg diltiazem (the regular treatment) twice a day. Then, their blood pressure was measured using a pressure set and symptoms of urinary system were
Sponsors
Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
55 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion: male patients ranging from 55 to 80, patients with prostatectomy; patients in urology department, patients with blood pressure background. Exclusion: patients with heart failure, bradycardia, having background of radiation to bladder, BCG therapy, systolic pressure less than 120 mm Hg, dependency of patient to medicine.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: A day before and four weeks after surgery. Method of measurement: With a pressure set.;Urinary system. Timepoint: A day before and four weeks after surgery. Method of measurement: Based on IPSS. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed